Trademark Overview
On Friday, December 2, 2011, a trademark application was filed for ENDOVE with the United States Patent and Trademark Office. The USPTO has given the ENDOVE trademark a serial number of 85485561. The federal status of this trademark filing is ABANDONED - EXPRESS as of Thursday, January 26, 2012. This trademark is owned by Glaxo Group Limited. The ENDOVE trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines